Top 5 Biotech Stocks That The Smart Money Doesn't Like – Benzinga

Preface: The biotech stocks considered for this review were confined to those over $10 per share that traded at least 500K shares a day based on a 90-day average.For the longest time it seemed that for every new high the S&P 500 hit, biotech stocks, as measured by the iShares Nasdaq Biotechnology Index (NASDAQ: IBB), hit two new highs.Biotechnology […]

Stock Market News for February 10, 2015 – Zacks Investment …

Markets ended in negative territory for second-consecutive day as intensified concern about Greece’s debt negotiations continued to hurt investor sentiment. Moreover, China’s disappointing trade data also had a negative impact on benchmarks on Monday. However, rise in oil prices limited some of the day’s losses.For a look at the issues currently facing the markets, make sure to read today’s Ahead […]

Leading Health Care Stock for Small-Cap Stars is Athersys Inc. (ATHX) for January 20

Leading Health Care Stock for Small-Cap Stars is Athersys Inc. (ATHX) for January 20
By iCELL News on January 22, 2015 · Investing
Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However,’s Small-Cap Stars, our proprietary list of small-cap companies with characteristics we’ve found […]

State Of The Union Lights Up Biotech

View photo.Biotech companies have been in the spotlight over the past few months with many investors considering the sector a goldmine for great investment opportunities. President Barack Obama in Tuesday’s State of the Union speech highlighted the need for more investment in medical research, a sign that biotech is set to continue as a hot spot in within the market.Precision […]

Are Momentum Stocks Losing Momentum?

Never mind how the U.S. stock market is posting modest year-to-date losses close to 2%. Momentum stocks are up and so is risk taking.A comparison of the iShares MSCI USA Momentum Factor ETF (MTUM) – a good proxy for the risk appetite of bullishly trending stocks – versus the S&P 500 (^GSPC) shows that momentum stocks have not yet lost their luster. Over the past […]

Get ready for a tale of two earnings seasons

Falling oil prices are bringing smiles to millions of Americans, but they’re also creating headaches for energy companies. Watch for this story to play out during the upcoming earnings season.
NEW YORK (CNNMoney)It’s the best of times for consumer and transportation companies. They are capitalizing on extremely cheap gas that’s left consumers flush with cash.As earnings season begins this week, […]

Pharma, Biotech Stocks Avoid Much Of Early New Year’s Malaise

In other news, a Food and Drug Administration advisory panel will meet Wednesday to decide whether to recommend approval for a biosimilar drug, which represents a potentially cheaper alternative to Amgen Inc. ’s Neupogen. If it gains agency approval, this drug would be the first biosimilar to get the FDA’s OK and it could mark the beginning of a new […]

Energy Stock Opportunities – Business Insider

Thomson ReutersTrader works on the floor of the NYSE in New YorkSee Also10 Charts That Predict The State Of The World In 2015China’s 2014 Slowdown In 7 Charts12 Financial Experts Weigh In On How To Grow Your Wealth In 2015NEW YORK (Reuters) – Last year was an ugly one for the U.S. energy sector, and while the first trading day […]

beneath the radar of my new caseworker

beneath the radar of my new caseworkerfictionedward w pritchardMy caseworker for my health insurance never calls me. She never asks me about my health or how my trips to the heart doctor went or responds or interacts towards me in any way at all really. That is except for threatening and high handled letters about dropping my benefits and ceasing […]

Best Performing Biotech Stocks of 2014 Include Agios …

The bull market is nearing six years old. It turns out that the biotech sector again managed a huge outperforming year in 2014 as well. The gains of the key biotech exchange traded funds (ETFs) were up in the 40% range, with the NYSE Arca Biotech index up over 45% year-to-date. The equal-weight biotech ETF performed better than the key larger […]